LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 341

Search options

  1. Article ; Online: A Post-Lockdown Assessment of Albendazole Treatment Coverage in Mass Drug Administration Campaigns Implemented Before and During COVID-19 Pandemic in Ekiti, Southwest Nigeria.

    Mogaji, Hammed O / Okoh, Hilary I / Lawal, Abiodun M / Ojo, Kayode H / Marcus, Ayodele J / Aaron, Nwana O / Adeleye, Damilola R / Olamiju, Francisca O / Ekpo, Uwem F

    International journal of public health

    2023  Volume 68, Page(s) 1605510

    Abstract: Objective: ...

    Abstract Objective:
    MeSH term(s) Child ; Humans ; Albendazole/therapeutic use ; Helminthiasis/drug therapy ; Helminthiasis/epidemiology ; Mass Drug Administration/methods ; Pandemics ; Nigeria/epidemiology ; COVID-19 ; Communicable Disease Control
    Chemical Substances Albendazole (F4216019LN)
    Language English
    Publishing date 2023-02-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2274130-6
    ISSN 1661-8564 ; 1661-8556
    ISSN (online) 1661-8564
    ISSN 1661-8556
    DOI 10.3389/ijph.2023.1605510
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Evolution of hierarchy in bacterial metabolic networks.

    Goodman, Aaron J / Feldman, Marcus W

    Bio Systems

    2019  Volume 180, Page(s) 71–78

    Abstract: Flow hierarchy is a useful way to characterize the movement of information and matter throughout a network. Hierarchical network organizations are shown to arise when there is a cost of maintaining links in the network. A similar constraint exists in ... ...

    Abstract Flow hierarchy is a useful way to characterize the movement of information and matter throughout a network. Hierarchical network organizations are shown to arise when there is a cost of maintaining links in the network. A similar constraint exists in metabolic networks, where costs come from reduced efficiency of nonspecific enzymes or from producing unnecessary enzymes. Previous analyses of bacterial metabolic networks have been used to predict the minimal nutrients that a bacterium needs to grow, its mutualistic relationships with other bacteria, and its major ecological niche. We use metabolic network inference to obtain metabolite flow graphs of 2935 bacterial metabolic networks and find that flow hierarchy evolves independently of modularity and other network properties. By inferring the ancestral metabolic networks and estimating the hierarchical character of the inferred network, we show that hierarchical structure first increased and later decreased over evolutionary history. Furthermore, hierarchical structure in the network is associated with slower growth rates; bacteria with hierarchy scores above the median grow on average 2.25 times faster than those with hierarchy scores below the median.
    MeSH term(s) Algorithms ; Bacteria/classification ; Bacteria/metabolism ; Biological Evolution ; Cluster Analysis ; Computer Simulation ; Metabolic Networks and Pathways ; Models, Biological
    Language English
    Publishing date 2019-03-13
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 186234-0
    ISSN 1872-8324 ; 0303-2647
    ISSN (online) 1872-8324
    ISSN 0303-2647
    DOI 10.1016/j.biosystems.2019.02.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases

    Aaron W Jurrjens / Marcus M Seldin / Corey Giles / Peter J Meikle / Brian G Drew / Anna C Calkin

    eLife, Vol

    2023  Volume 12

    Abstract: Cardiometabolic diseases encompass a range of interrelated conditions that arise from underlying metabolic perturbations precipitated by genetic, environmental, and lifestyle factors. While obesity, dyslipidaemia, smoking, and insulin resistance are ... ...

    Abstract Cardiometabolic diseases encompass a range of interrelated conditions that arise from underlying metabolic perturbations precipitated by genetic, environmental, and lifestyle factors. While obesity, dyslipidaemia, smoking, and insulin resistance are major risk factors for cardiometabolic diseases, individuals still present in the absence of such traditional risk factors, making it difficult to determine those at greatest risk of disease. Thus, it is crucial to elucidate the genetic, environmental, and molecular underpinnings to better understand, diagnose, and treat cardiometabolic diseases. Much of this information can be garnered using systems genetics, which takes population-based approaches to investigate how genetic variance contributes to complex traits. Despite the important advances made by human genome-wide association studies (GWAS) in this space, corroboration of these findings has been hampered by limitations including the inability to control environmental influence, limited access to pertinent metabolic tissues, and often, poor classification of diseases or phenotypes. A complementary approach to human GWAS is the utilisation of model systems such as genetically diverse mouse panels to study natural genetic and phenotypic variation in a controlled environment. Here, we review mouse genetic reference panels and the opportunities they provide for the study of cardiometabolic diseases and related traits. We discuss how the post-GWAS era has prompted a shift in focus from discovery of novel genetic variants to understanding gene function. Finally, we highlight key advantages and challenges of integrating complementary genetic and multi-omics data from human and mouse populations to advance biological discovery.
    Keywords systems genetics ; multi-omics ; genetic reference panels ; genome-wide association studies ; genetic mapping ; Hybrid Mouse Diversity Panel ; Medicine ; R ; Science ; Q ; Biology (General) ; QH301-705.5
    Subject code 610
    Language English
    Publishing date 2023-03-01T00:00:00Z
    Publisher eLife Sciences Publications Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: New approaches for measurement of platelet reactivity.

    Marcus, Aaron J

    Blood

    2012  Volume 119, Issue 15, Page(s) 3378–3379

    Abstract: In a highly interesting, intricate, and novel paper in this issue of Blood, Fung and colleagues have extended their previous pioneering studies and now reveal that molecules such as ATP can promote platelet activation through the P2X1 receptor. ...

    Abstract In a highly interesting, intricate, and novel paper in this issue of Blood, Fung and colleagues have extended their previous pioneering studies and now reveal that molecules such as ATP can promote platelet activation through the P2X1 receptor.
    MeSH term(s) Animals ; Blood Platelets/metabolism ; Calcium/metabolism ; Humans ; Platelet Membrane Glycoproteins/metabolism ; Receptors, Purinergic P2X1/metabolism ; Toll-Like Receptors/metabolism
    Chemical Substances Platelet Membrane Glycoproteins ; Receptors, Purinergic P2X1 ; Toll-Like Receptors ; platelet membrane glycoprotein VI ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2012-04-12
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2012-01-403717
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases.

    Jurrjens, Aaron W / Seldin, Marcus M / Giles, Corey / Meikle, Peter J / Drew, Brian G / Calkin, Anna C

    eLife

    2023  Volume 12

    Abstract: Cardiometabolic diseases encompass a range of interrelated conditions that arise from underlying metabolic perturbations precipitated by genetic, environmental, and lifestyle factors. While obesity, dyslipidaemia, smoking, and insulin resistance are ... ...

    Abstract Cardiometabolic diseases encompass a range of interrelated conditions that arise from underlying metabolic perturbations precipitated by genetic, environmental, and lifestyle factors. While obesity, dyslipidaemia, smoking, and insulin resistance are major risk factors for cardiometabolic diseases, individuals still present in the absence of such traditional risk factors, making it difficult to determine those at greatest risk of disease. Thus, it is crucial to elucidate the genetic, environmental, and molecular underpinnings to better understand, diagnose, and treat cardiometabolic diseases. Much of this information can be garnered using systems genetics, which takes population-based approaches to investigate how genetic variance contributes to complex traits. Despite the important advances made by human genome-wide association studies (GWAS) in this space, corroboration of these findings has been hampered by limitations including the inability to control environmental influence, limited access to pertinent metabolic tissues, and often, poor classification of diseases or phenotypes. A complementary approach to human GWAS is the utilisation of model systems such as genetically diverse mouse panels to study natural genetic and phenotypic variation in a controlled environment. Here, we review mouse genetic reference panels and the opportunities they provide for the study of cardiometabolic diseases and related traits. We discuss how the post-GWAS era has prompted a shift in focus from discovery of novel genetic variants to understanding gene function. Finally, we highlight key advantages and challenges of integrating complementary genetic and multi-omics data from human and mouse populations to advance biological discovery.
    MeSH term(s) Animals ; Humans ; Mice ; Cardiovascular Diseases/genetics ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Obesity/genetics ; Phenotype ; Risk Factors
    Language English
    Publishing date 2023-03-31
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.86139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Urinary microbiome differences between lichen sclerosus induced and non-lichen sclerosus induced urethral stricture disease.

    Jamil, Marcus L / Perecman, Aaron / Sherman, Amanda / Sullivan, Travis / Christ, Kimberly / Hansma, Alexandra / Burks, Eric / Vanni, Alex J

    World journal of urology

    2023  Volume 41, Issue 9, Page(s) 2495–2501

    Abstract: Objective: To describe differences in the urinary microbiome of patients with pathologically confirmed lichen sclerosus (LS) urethral stricture disease (USD) vs non-lichen sclerosus (non-LS) USD pre- and post-operatively.: Methods: Patients were pre- ... ...

    Abstract Objective: To describe differences in the urinary microbiome of patients with pathologically confirmed lichen sclerosus (LS) urethral stricture disease (USD) vs non-lichen sclerosus (non-LS) USD pre- and post-operatively.
    Methods: Patients were pre-operatively identified and prospectively followed, all underwent surgical repair and had tissue samples obtained to make a pathological diagnosis of LS. Pre- and post-operative urine samples were collected. Bacterial genomic DNA was extracted. Alpha and beta diversity measurements were calculated and compared. A zero-inflated negative binomial model was utilized to compare taxa abundances between disease status and surgery status.
    Results: Urine samples were obtained from both cohorts, 69 samples in total: 36 samples were obtained pre-operatively and 33 samples were obtained post-operatively. Ten patients provided both a pre-operative and post-operative urine sample. Twenty-six patients had pathological evidence of LS and 33 patients did not. There was a statistically significant difference in alpha diversity between the pre-operative urine samples of patients with non-LS USD and LS USD, (p = 0.01). There was no significant difference in alpha diversity within post-operative urine samples between patients with non-LS USD and LS USD, (p = 0.1). A significant difference was observed in Weighed UniFrac distances with respect to disease and operative status, (p = 0.001 and 0.002).
    Conclusions: LS USD have significant alterations in diversity and differential abundance of urine microbiota compared to non-LS USD controls. These findings could be used to guide further investigations into the role of the urinary microbiome in LS USD pathogenesis, severity of presentation, and stricture recurrence.
    MeSH term(s) Humans ; Urethral Stricture/etiology ; Constriction, Pathologic ; Lichen Sclerosus et Atrophicus/complications ; Lichen Sclerosus et Atrophicus/pathology
    Language English
    Publishing date 2023-07-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 380333-8
    ISSN 1433-8726 ; 0724-4983
    ISSN (online) 1433-8726
    ISSN 0724-4983
    DOI 10.1007/s00345-023-04490-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Predicting variable gene content in

    Nguyen, Marcus / Elmore, Zachary / Ihle, Clay / Moen, Francesco S / Slater, Adam D / Turner, Benjamin N / Parrello, Bruce / Best, Aaron A / Davis, James J

    mSystems

    2023  Volume 8, Issue 4, Page(s) e0005823

    Abstract: Having the ability to predict the protein-encoding gene content of an incomplete genome or metagenome-assembled genome is important for a variety of bioinformatic tasks. In this study, as a proof of concept, we built machine learning classifiers for ... ...

    Abstract Having the ability to predict the protein-encoding gene content of an incomplete genome or metagenome-assembled genome is important for a variety of bioinformatic tasks. In this study, as a proof of concept, we built machine learning classifiers for predicting variable gene content in
    MeSH term(s) Escherichia coli/genetics ; Genome, Bacterial/genetics ; Plasmids ; Escherichia coli Proteins/genetics ; Anti-Infective Agents
    Chemical Substances Escherichia coli Proteins ; Anti-Infective Agents
    Language English
    Publishing date 2023-06-14
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2379-5077
    ISSN (online) 2379-5077
    DOI 10.1128/msystems.00058-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Changes in adipose tissue distribution and relation to cardiometabolic risk factors after Roux-en-Y gastric bypass in adolescents.

    Beamish, Andrew J / Dengel, Olivia H / Palzer, Elise F / Gronowitz, Eva / Kelly, Aaron S / Dengel, Donald R / Rudser, Kyle D / Brissman, Markus / Olbers, Torsten / Dahlgren, Jovanna / Flodmark, Carl-Erik / Marcus, Claude / Ryder, Justin R

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

    2023  Volume 19, Issue 10, Page(s) 1154–1161

    Abstract: Background: Roux-en-Y gastric bypass (RYGB) among adolescents with obesity results in significant weight loss; however, depot-specific changes have been understudied.: Objective: We hypothesized that visceral adipose tissue (VAT) reduction in ... ...

    Abstract Background: Roux-en-Y gastric bypass (RYGB) among adolescents with obesity results in significant weight loss; however, depot-specific changes have been understudied.
    Objective: We hypothesized that visceral adipose tissue (VAT) reduction in adolescents undergoing RYGB would be greater than other depots and associated with improvement in cardiometabolic risk factors.
    Setting: Three specialized treatment centers in Sweden.
    Methods: Fifty-nine adolescents underwent dual x-ray absorptiometry before surgery and at 1, 2, and 5 years after RYGB. Changes in body composition in multiple depots (total fat, lean body, gynoid fat, android fat, subcutaneous adipose tissue, and VAT) and cardiometabolic risk factors were assessed using multiple linear regression analysis and generalized estimating equations adjusting for age, sex, and baseline risk factor levels. Data are presented as percent change (95% CI) with regression models showing slopes and estimated P values.
    Results: At 1 year post-RYGB, a significant reduction was observed across all body composition measures (P < .001) with the greatest reduction observed in VAT (-65.1% [-68.7, -61.8]). From year 1 to 5 years post-RYGB, a regain was observed in all depots except lean body mass (1.2% [.3, 2.7], P = .105). A sex-specific difference in overall trajectories was only observed in lean body mass with males consistently having higher mean levels. Change in VAT at 1 year correlated with change in triglycerides (slope: .21 mg/dL/kg, P = .034) and fasting plasma insulin (slope: 44 pmol/L/kg, P = .027).
    Conclusions: Adiposity measures all decreased after RYGB but poorly predicted change in cardiometabolic risk. Despite significant reductions at 1 year, a steady regain was observed out to 5 years, with values still well below baseline. Further research should consider control group comparison and extended follow-up.
    MeSH term(s) Male ; Female ; Humans ; Adolescent ; Gastric Bypass/methods ; Cardiometabolic Risk Factors ; Tissue Distribution ; Obesity/surgery ; Body Fat Distribution
    Language English
    Publishing date 2023-04-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2274243-8
    ISSN 1878-7533 ; 1550-7289
    ISSN (online) 1878-7533
    ISSN 1550-7289
    DOI 10.1016/j.soard.2023.04.326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.

    Cash, Thomas / Krailo, Mark D / Buxton, Allen B / Pawel, Bruce R / Healey, John H / Binitie, Odion / Marcus, Karen J / Grier, Holcombe E / Grohar, Patrick J / Reed, Damon R / Weiss, Aaron R / Gorlick, Richard / Janeway, Katherine A / DuBois, Steven G / Womer, Richard B

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2023  Volume 41, Issue 30, Page(s) 4724–4728

    Abstract: Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical trial ... ...

    Abstract Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical trial updates provide an opportunity to disseminate additional results from studies, published in
    MeSH term(s) Humans ; Child ; Sarcoma, Ewing/pathology ; Bone Neoplasms/therapy ; Etoposide ; Ifosfamide ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Doxorubicin ; Vincristine
    Chemical Substances Etoposide (6PLQ3CP4P3) ; Ifosfamide (UM20QQM95Y) ; Doxorubicin (80168379AG) ; Vincristine (5J49Q6B70F)
    Language English
    Publishing date 2023-08-31
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.23.00053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A Post-Lockdown Assessment of Albendazole Treatment Coverage in Mass Drug Administration Campaigns Implemented Before and During COVID-19 Pandemic in Ekiti, Southwest Nigeria

    Hammed O. Mogaji / Hilary I. Okoh / Abiodun M. Lawal / Kayode H. Ojo / Ayodele J. Marcus / Nwana O. Aaron / Damilola R. Adeleye / Francisca O. Olamiju / Uwem F. Ekpo

    International Journal of Public Health, Vol

    2023  Volume 68

    Abstract: Objective: This study assessed the coverage of albendazole (ALB) in mass drug administration (MDA) programs implemented before (2019) and during the (2020 and 2021) COVID-19 pandemic in Ekiti State, Nigeria.Methods: Standardized questionnaires were ... ...

    Abstract Objective: This study assessed the coverage of albendazole (ALB) in mass drug administration (MDA) programs implemented before (2019) and during the (2020 and 2021) COVID-19 pandemic in Ekiti State, Nigeria.Methods: Standardized questionnaires were administered to 1,127 children across three peri-urban communities to ascertain if they received and swallowed ALB across the years. Reasons, why ALB was not received, were documented and analyzed in SPSS. 20.0.Results: In 2019, the medicine reach was between 42.2%–57.8%, however, during the pandemic, the reach significantly reduced to 12.3%–18.6%, and increased to 28.5%–35.2% in 2021 (p < 0.000). About 19.6%–27.2% of the participants have missed 1 MDA, while 26.9%–37.8% and 22.4%–32.8% have missed 2 and 3 MDAs, respectively. The majority who did not receive ALB (60.8%–75%) claimed drug distributors never came, while about 14.9%–20.3% mentioned they did not hear about MDA. However, individual compliance towards swallowing was above 94% across the study years (p < 0.00).Conclusion: These results highlight the need to explore the perceptions of those who have consistently missed MDAs, and also understand the health-system-related issues including those imposed by the pandemic affecting MDA.
    Keywords COVID-19 ; Nigeria ; soil-transmitted helminthiasis ; albendazole ; mass drug administration ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2023-02-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top